State of New Jersey Common Pension Fund D Sells 14,466 Shares of Avantor, Inc. (NYSE:AVTR)

State of New Jersey Common Pension Fund D lessened its holdings in shares of Avantor, Inc. (NYSE:AVTRFree Report) by 3.6% in the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 384,707 shares of the company’s stock after selling 14,466 shares during the period. State of New Jersey Common Pension Fund D owned about 0.06% of Avantor worth $8,110,000 at the end of the most recent reporting period.

Several other large investors have also modified their holdings of AVTR. Raymond James Financial Services Advisors Inc. boosted its holdings in shares of Avantor by 43.5% in the first quarter. Raymond James Financial Services Advisors Inc. now owns 27,092 shares of the company’s stock valued at $916,000 after purchasing an additional 8,211 shares during the period. MetLife Investment Management LLC purchased a new stake in shares of Avantor in the first quarter valued at approximately $1,318,000. Panagora Asset Management Inc. boosted its holdings in shares of Avantor by 67.9% in the first quarter. Panagora Asset Management Inc. now owns 19,061 shares of the company’s stock valued at $645,000 after purchasing an additional 7,710 shares during the period. Yousif Capital Management LLC boosted its holdings in shares of Avantor by 7.9% in the first quarter. Yousif Capital Management LLC now owns 8,870 shares of the company’s stock valued at $300,000 after purchasing an additional 650 shares during the period. Finally, Raymond James Trust N.A. boosted its holdings in shares of Avantor by 28.8% in the first quarter. Raymond James Trust N.A. now owns 7,342 shares of the company’s stock valued at $248,000 after purchasing an additional 1,643 shares during the period. Hedge funds and other institutional investors own 89.04% of the company’s stock.

Analysts Set New Price Targets

A number of analysts have weighed in on AVTR shares. Barclays upped their target price on Avantor from $21.00 to $24.00 and gave the stock an “overweight” rating in a report on Monday, December 11th. Royal Bank of Canada restated an “outperform” rating and set a $28.00 target price on shares of Avantor in a report on Tuesday, January 9th. TD Cowen upgraded Avantor from a “market perform” rating to an “outperform” rating and upped their target price for the stock from $21.00 to $28.00 in a report on Monday, December 11th. Wolfe Research started coverage on Avantor in a report on Wednesday, December 13th. They set a “peer perform” rating for the company. Finally, Raymond James increased their price objective on Avantor from $22.50 to $26.00 and gave the company an “outperform” rating in a report on Friday, January 26th. Four research analysts have rated the stock with a hold rating and nine have issued a buy rating to the company’s stock. According to MarketBeat.com, Avantor currently has an average rating of “Moderate Buy” and an average target price of $24.55.

Check Out Our Latest Research Report on Avantor

Avantor Stock Performance

Shares of AVTR stock opened at $23.21 on Monday. The firm has a market capitalization of $15.70 billion, a price-to-earnings ratio of 42.98, a price-to-earnings-growth ratio of 1.41 and a beta of 1.36. The company has a debt-to-equity ratio of 1.04, a current ratio of 1.60 and a quick ratio of 1.03. The business has a fifty day moving average of $22.38 and a 200 day moving average of $21.18. Avantor, Inc. has a 1 year low of $16.63 and a 1 year high of $25.25.

Avantor Company Profile

(Free Report)

Avantor, Inc engages in the provision of mission-critical products and services to customers in biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa. The company offers materials and consumables, such as purity chemicals and reagents, lab products and supplies, formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits, education and microbiology products, clinical trial kits, peristaltic pumps, and fluid handling tips.

Featured Articles

Institutional Ownership by Quarter for Avantor (NYSE:AVTR)

Receive News & Ratings for Avantor Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Avantor and related companies with MarketBeat.com's FREE daily email newsletter.